Analyst Research

Report Title Price
Provider: ValuEngine, Inc.
$25.00
Provider: Finlabo SIM Spa
$10.00
Provider: Reuters Investment Profile
$20.00
Provider: Reuters Investment Profile
$20.00

NYSE and AMEX quotes delayed by at least 20 minutes. NASDAQ delayed by at least 15 minutes. For a complete list of exchanges and delays, please click here.

Bayer AG Starts Clinical Trial Of Drug For Children With Haemophilia-Reuters


Monday, 8 Jul 2013 02:41am EDT 

Reuters reported that Bayer AG announced it had started a late stage clinical trial of its drug BAY 94-9027 for prophylaxis and treatment of bleeding in previously treated children with severe haemophilia A. 

Company Quote

101.1
0.3 +0.30%
6:07am EDT